MeritValue

GUIDED THERAPEUTICS INC

GTHPdata completeness 88%16 fiscal years on file

Data notes: no data for concept 'investmentsAtFairValue'; no data for concept 'netInvestmentIncome'; no data for concept 'gainsOnRealEstateSales'; no data for concept 'realEstateImpairment'; no data for concept 'dividendsPaid'

i. The business — what you’d actually own
FigureFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue$81,0001$13,0002$98,0003$7,0004$767,0004
Net income−$2.07M5−$4.34M6−$3.49M7−$2.42M8−$3.2M8
Operating cash flow−$1.59M9−$1.48M10−$1.75M11−$1.12M12−$1.07M12
Capital expenditure$14,00013$31,00014$014$015$2,00015
Free cash flow (derived)−$1.61M9−$1.51M10−$1.75M11−$1.12M12−$1.07M12
Total debt$930,00016$17,00016$017——
Cash & equivalents$643,00018$2.31M18$591,00019$388,00019$63,00019
Diluted shares13.4M32.5M51.1M57.3M78.4M

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).

ii. Your slice — ownership made literal
If you owned
shares
Net assets behind them
−$0.77
your share of equity
Profit it earned you last year
−$0.41
Free cash flow it threw off
−$0.14
Debt you’d be carrying
—

10 shares is a claim on −$0.77 of net worth that earned you −$0.41 and generated −$0.14 of cash last year.

iii. Is this a good business?
Moat signal · return on equity
— avg · 5y

Not enough data in the filings for a return-on-capital reading.

seeing a moat in the numbers →
Management signal · capital allocation
+486% shares · 5y

Share count is up 486% over 5 years — owners have been diluted. Worth asking what they got for it. Total debt has fallen 100% — deleveraging.

reading capital allocation →

Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.

iv. What it’s worth — engine v0.5.0
DCF · Growth Exit 10Y
not applicable
3y-median FCF non-positive — growth-exit DCF not applicable (see EPV)
DCF · Growth Exit 5Y
not applicable
3y-median FCF non-positive — growth-exit DCF not applicable (see EPV)
Earnings Power Value
not applicable
normalized (5y-median) earnings non-positive — EPV undefined
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined

Different models answer different questions — which to trust when →

Sources — the receipts
  1. 10-K · period ending 2021-12-31 · accession 0001477932-23-001899 (Revenues)
  2. 10-K · period ending 2022-12-31 · accession 0001477932-24-001549 (Revenues)
  3. 10-K · period ending 2023-12-31 · accession 0001477932-25-002200 (Revenues)
  4. 10-K · period ending 2024-12-31 · accession 0001477932-26-001723 (Revenues)
  5. 10-K · period ending 2021-12-31 · accession 0001477932-23-001899 (NetIncomeLoss)
  6. 10-K · period ending 2022-12-31 · accession 0001477932-24-001549 (NetIncomeLoss)
  7. 10-K · period ending 2023-12-31 · accession 0001477932-25-002200 (NetIncomeLoss)
  8. 10-K · period ending 2024-12-31 · accession 0001477932-26-001723 (NetIncomeLoss)
  9. 10-K · period ending 2021-12-31 · accession 0001477932-23-001899 (NetCashProvidedByUsedInOperatingActivities)
  10. 10-K · period ending 2022-12-31 · accession 0001477932-24-001549 (NetCashProvidedByUsedInOperatingActivities)
  11. 10-K · period ending 2023-12-31 · accession 0001477932-25-002200 (NetCashProvidedByUsedInOperatingActivities)
  12. 10-K · period ending 2024-12-31 · accession 0001477932-26-001723 (NetCashProvidedByUsedInOperatingActivities)
  13. 10-K · period ending 2021-12-31 · accession 0001477932-23-001899 (PaymentsToAcquirePropertyPlantAndEquipment)
  14. 10-K · period ending 2022-12-31 · accession 0001477932-24-001549 (PaymentsToAcquirePropertyPlantAndEquipment)
  15. 10-K · period ending 2024-12-31 · accession 0001477932-26-001723 (PaymentsToAcquirePropertyPlantAndEquipment)
  16. 10-K · period ending 2021-12-31 · accession 0001477932-23-001899 (LongTermDebtNoncurrent)
  17. 10-K · period ending 2023-12-31 · accession 0001477932-24-001549 (LongTermDebtCurrent)
  18. 10-K · period ending 2021-12-31 · accession 0001477932-23-001899 (CashAndCashEquivalentsAtCarryingValue)
  19. 10-K · period ending 2023-12-31 · accession 0001477932-26-001723 (CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents)